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Abstract
Background: Recent studies have identified stem/progenitor cells in human and mouse uterine epithelium, which are
postulated to be responsible for tissue regeneration and proliferative disorders of human endometrium. These progenitor
cells are thought to be derived from Mu ¨llerian duct (MD), the primordial female reproductive tract (FRT).
Methodology/Principal Findings: We have developed a model of human reproductive tract development in which
inductive neonatal mouse uterine mesenchyme (nMUM) is recombined with green fluorescent protein (GFP)-tagged human
embryonic stem cells (hESCs); GFP-hESC (ENVY). We demonstrate for the first time that hESCs can be differentiated into cells
with a human FRT epithelial cell phenotype. hESC derived FRT epithelial cells emerged from cultures containing MIXL1
+
mesendodermal precursors, paralleling events occurring during normal organogenesis. Following transplantation, nMUM
treated embryoid bodies (EBs) generated epithelial structures with a typical MD phenotype that expressed the MD markers
PAX2, HOXA10. Functionally, the hESCs derived FRT epithelium responded to exogenous estrogen by proliferating and
secreting uterine-specific glycodelin A (GdA).
Conclusions/Significance: These data show nMUM can induce differentiation of hESC to form the FRT epithelium. This may
provide a model to study early developmental events of the human FRT.
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Introduction
During embryogenesis, the mesoderm emerges from the pri-
mitive streak and gives rise to coelomic epithelium. The Mu ¨llerian
Duct (MD) arises from invagination of coelomic epithelium during
fetal development. Subsequently, the MD gives rise to the human
female reproductive tract (FRT) that further differentiates to form
the oviduct, uterus and upper vaginal canal. The mucosal lining of
the uterus is known for its remarkable regenerative capacity during
a female’s reproductive years. Recently, the regenerative capacity
of the endometrium has been attributed to a small population of
resident stem/progenitor cells. Our laboratory discovered these
cells in both the stroma and epithelium of the adult human and
murine uterus [1,2,3]. We have identified cell surface markers that
enrich for endometrial mesenchymal/stromal stem/progenitor
cells, and ongoing investigations now focus on finding definitive
markers for the epithelial stem/progenitor cells. Identifying and
characterising these stem/progenitor cells will provide a better
understanding of the normal cyclical regenerative processes in
human endometrium and the pathophysiology of human endo-
metrial proliferative diseases, such as endometriosis, endometrial
hyperplasia and endometrial cancer.
Recent studies have shown that creating developmental models
from embryonic stem cells (ESCs) is a tractable approach to track
and potentially identify adult stem/progenitor cells [4,5]. In this
context, we believe a hESC based model of human MD develop-
ment will facilitate the identification and characterization of female
reproductive tract stem/progenitor cells. Tissue recombination is a
powerful tool for studying stromal-epithelial interactions. For
example, neonatal mouse uterine mesenchyme (nMUM) had been
recombined with human and mouse uterine epithelial cells in
previous tissue recombination experiments [6,7,8,9]. nMUM also
transdifferentiates pluripotent spermatogonial stem cells into
murine uterine epithelial tissue [10] and a number of studies have
shown that specific stromal populations can direct ESC differenti-
ation towards derivatives of their corresponding epithelia, including
bladder, prostate and oocytes [4,5,11]. We hypothesized that
nMUM might provide inductive cues capable of directing hESCs to
differentiate into human FRT epithelium. We adopted established
methods for hESC differentiation to form embryoid bodies (EB)
from green fluorescent protein-tagged hESCs; GFP-hESCs
(ENVY). EBs were then combined with nMUM and the resultant
recombinant subsequentlty grafted into immunocompromised
mice. We demonstrated that nMUM induced differentiation of
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21136hESCs to form human FRT epithelium in a process that paralleled
known stages of human FRT organogenesis.
Results
Neonatal mouse uterine mesenchyme directed hESCs to
form human female reproductive tract epithelium in vivo
No single marker defines the adult FRT epithelium which in-
cludes the oviduct, uterus and upper vaginal canal. Therefore we
used a previously established combination of a morphological
marker (cilia) and the immunohistochemical markers cancer an-
tigen 125 (CA125), Glycodelin A (GdA) and estrogen receptor
alpha (ER-a) to identify the FRT epithelium [12,13]. As a prelude
to experiments utilising nMUM mesenchyme, we first tested the
ability of differentiating hESCs to spontaneously differentiate into
human FRT epithelium following transplantation. To this end, we
grafted ovariectomized mice with two types of controls; EBs
formed in the absence of growth factors (n=4) or EBs treated with
BMP4/ACTIVIN A (n=4), growth factors known to induce
hESCs to differentiate towards mesendoderm, an obligate inter-
mediate during FRT development. Lack of ovarian hormones
does not impair ciliogenesis or development of the female repro-
ductive tract [14,15,16], but the absence of these hormones
enables distinction of reproductive and respiratory tract epithelia.
Specifically, under these conditions, normal human uterine epithe-
lium is a ciliated simple columnar epithelium (Figure 1A), in
contrast, respiratory epithelium is ciliated and pseudostratified
(data not shown). We found no evidence of ciliated simple colum-
nar epithelium in either control group, however, we detected
ciliated pseudostratified columnar epithelium resembling respira-
tory epithelium similar to that described in a previous report [17].
In addition to these hESC controls, we also grafted nMUM alone
and found no evidence of epithelial differentiation, consistent with
previous studies (data not shown) [7,10]. In the experimental
groups, we detected ciliated simple columnar epithelium in each
graft derived from both the non-growth factor treated (n=2) (data
not shown) and growth factor treated EB/nMUM recombinant
tissues (n=30) (Figure 1B, C). Grafts derived from these samples
were smaller than those arising from EBs formed in the absence of
nMUM and/or growth factors, (Figure S1A), consistent with
previous studies showing that differentiated hESC had reduced
the potential for teratoma formation [5,17]. We also found the
viability of hESC differed between immunodeficient host mouse
strains and that NOD.Scid gamma (NSG) mice were ideal for
hESC cell development compared to NOD.Scid mice (data not
shown) consistent with a previous study [18].
In order to confirm that ciliated structures were indeed hESC
derived epithelium, we used a combination of Hoechst stain and anti-
GFP antibody staining (Figure 1C–F, Figure S6A). This analysis
enabled GFP
+ ENVY-derived human epithelial cells containing
smooth Hoechst-stained nuclei to be distinguished from GFP
2 mouse
cells with speckled nuclei [19]. In week 8 recombinant grafts, ciliated
simple columnar epithelium was only observed when surrounded by
mouse stromal cells (Figure 1C). In GF-treated week 8 recombinant
grafts, we found epithelial tissue made up a small percentage of the
total area (4.862.3%), and that ciliated simple columnar human
epithelium accounted for 33.8622.6% of all epithelial structures
(n=4, mean6s.e.m.). Consistent with a previous report, our data
showed that a considerable portion of each graft consisted of non-
epithelial tissue and fluid filled cavities (Figure S1C) [17]. In addition,
the proportion of ciliated simple columnar epithelial structures in
recombinant grafts varied; for instance, in one graft, the only epithelial
structure present was ciliated whilst the rest of the graft consisted of
fluid-filled cavities (Figure S1C). In other grafts, several hESC derived
FRT epithelial structures were present (Figure S1B, Figure S1D).
Despite this variability, structures with characteristics consistent with
FRT epithelium were found in all grafts where both nMUM and
hESC derived cell types were present (n=30) (Figure S2).
Immunofluorescence analysis indicated that the hESC derived
FRT epithelium expressed human CK18 and CA125 (Figure 1D,
Figure 1E). This result excludes the possibility that these structures
represented luminal epithelium of the male reproductive tract or
ependymal epithelium of the central nervous system, which do not
express CA125 [20]. Following exogenous estrogen treatment,
estrogen receptor-a (ERa) was detected in the hESC derived FRT
epithelium (Figure 1F, Figure S4A) albeit at a low frequency and
variable intensity, comparable to ERa expression in human
endometrial glands (Figure 1G, Figure S4C, Figure S4D). In
recombinant grafts, ERa is only detected in mouse stromal cells
and hESC derived FRT epithelium (Figure S4A, Figure S4B). To
assess the functional capacity of the hESC derived FRT epithe-
lium, we treated host mice with multiple estrogen injections over 5
days [9]. Estrogen induced epithelial proliferation, as demonstrat-
ed by Ki67 expression (Figure 1I), similarly, the hESC derived
epithelia in estrogen treated animals expressed GdA in the cyto-
plasm (Figure 1K). We also observed morphological changes in
response to exogenous hormonal stimulation, the hESC derived
FRT epithelium increased in height, whilst the underlying stromal
cells demonstrated edematous change (Figure 1M), mirroring
changes that occur in normal cycling adult proliferative uterine
epithelium and stroma (Figure 1N). In contrast, grafts from vehicle
alone treated hosts contained low cuboidal epithelium and lacked
stromal edema (Figure 1L). Furthermore evidence of reciprocal
interaction between differentiated human epithelial cells and
mouse endometrial stromal cells was indicated by the expression of
alpha - smooth muscle actin (a-SMA) in the latter (Figure 1O),
consistent with previous studies [4,5]. Collectively, these results
demonstrate that nMUM can direct hESCs to differentiate into
hormonally responsive FRT epithelium.
FRT epithelia arises from MIXL
+ embryoid bodies
Since MD is derived from primitive streak mesendoderm, we
sought to determine if nMUM induced formation of mesendo-
dermal cells in differentiating human EBs. To examine this
process, we generated EBs with a MIXL1
GFP/w hESC reporter line
in which GFP expression has been placed under the control of the
of the primitive streak gene, MIXL1. We detected GFP expression
as early as day 3 in developing EBs cultured in serum-free-medium
in the presence of nMUM (Figure 2A). Reporter activity in the
recombinant EBs, which paralleled that seen in EBs treated with
growth factors (BMP4 and ACTIVIN A), first appeared on day 3
and gradually diminished by day 7 (Figure 2A). Furthermore, in
larger EBs (.4000 cells), reporter activity was localised to the area
of contact between EB and mesenchyme (Figure 2B, Figure S3).
When we recombined MIXL1
GFP/w EBs with neonatal mouse
uterine epithelial (nMUE) cells under serum free conditions, we
observed no reporter activity (Figure 2C). These observations
suggest close range morphogens from nMUM, but not nMUE,
directed the differentiation of hESC to mesendodermal cells in
MIXL1
GFP/w EBs. These observations indicate that nMUM, but
not nMUE, produced factors capable of directing the differenti-
ation of hESCs to mesendodermal progenitors.
Expression of mesoderm markers in EBs induced to
differentiate with nMUM
We hypothesized that nMUM might induce the differentiation
of MIXL1
+ mesendodermal progenitors to mesoderm with cha-
racteristics of lateral plate mesoderm. In the first instance, we
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mesendoderm and mesoderm in the differentiating recombinant
ENVY EBs from day 3 to day 9 using qRT-PCR. In the presence
of growth factors (BMP4 and ACTIVIN A) alone, MIXL1,
Brachyury (T), PAX2, were rapidly upregulated and slowly declined
over time (Figure 3). Goosecoid (GSC), and OSR1 increased over time
compared to control (no growth factor). High levels of MIXL1,
GSC, and T suggest differentiation of hESCs towards anterior
population of mesendodermal cells, consistent with the role of
ACTIVIN A [21,22]. In addition, we also observed the
upregulation of intermediate and lateral plate mesodermal
markers OSR1 and PAX2, consistent with a previous study,
suggesting that under these conditions, EBs potentially harbour a
precursor of MD [23]. nMUM upregulated MIXL1, T, and GSC as
early as day 3, but there was delayed upregulation of OSR1
compared to growth factor treated EBs (Figure 3). PAX2 showed
Figure 1. Characterisation of hESC-derived FRT epithelium in GF treated heterotypic (nMUM) recombinant 8 week xenograft. b-
tubulin expression in (A) ciliated simple columnar epithelia of human adult proliferative endometrium and (B) in hESC derived ciliated, simple
columnar FRT epithelium (arrows indicates cilia). (C) immunofluorescence analysis of hESC derived FRT epithelium (green) where b-tubulin (yellow
orange) is expressed on cell surface (inset shows a close up view of the cilia), the hESC origin of epithelial cells was assigned on the basis of GFP
expression. Note that adjacent mouse uterine stromal cells are GFP
2. hESC derived FRT epithelium co-localised (D) cytoplasmic CK18, (E) CA125 on
epithelial surface (arrow), and (F)E R a (pink) with GFP
+ hESC derived epithelial cells. Weak ERa expression was also evident in mouse uterine stromal
cells (filled arrows). (G)E R a expression in human proliferative endometrial gland (full arrows), dotted line indicates epithelium. Ki67 expression in
hESC derived FRT epithelium before (H) and after (I) estrogen injections showing estrogen-induced epithelial cell proliferation. The expression of GdA
in hESC derived FRT epithelium without (J) and with (K) estrogen injections showing estrogen-induced cytoplasmic expression of GdA. H&E of hESC
derived FRT epithelium lined by simple columnar cells without (L) and with (M) estrogen treatment, showing estrogen-induced increase in epithelial
height and stromal oedema (arrows), classical hormonal responses of adult uterine epithelium (N). (O) Three hESC derived FRT epithelial structures
surrounded by a-SMA positive cells. Inset in (K) is concentration matched mouse IgG1 negative control. Hoechst stained serial sections
corresponding to (I) and (K) are found in Figure S6E–F. Abbreviations: a-SMA, a-smooth muscle actin; CA125, cancer antigen 125; E, epithelium; ERa,
estrogen receptor alpha; E2, estrogen; G, gland; GdA, glycodelin A; S, stroma.
doi:10.1371/journal.pone.0021136.g001
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profiles of recombinant EBs treated with growth factors were
similar to that of EBs treated with growth factor alone, although
the nMUM appeared to maintain higher levels of expression for
MIXL1, and T, on day 9 compared to GF treated EBs (Figure 3).
The pluripotency marker Oct4 decreased steadily over time in all
groups except control. These results suggest that in the absence of
growth factors, nMUM can promote hESC differentiation towards
mesendoderm, albeit less efficiently than BMP4/ACTIVIN A.
However, despite the similar gene expression profile of growth
factor only treated EBs and growth factor treated EB/nMUM
recombinants, the former never developed FRT epithelium
following transplantation.
nMUM induced differentiation of hESCs recapitulates
aspects of rodent and human Mu ¨llerian Duct development
To investigate the kinetics of MD development following EB
transplantation, we harvested recombinant grafts at 2 and 4 weeks.
hESC-derived FRT epithelial structures were detected at both time
points (Figure 4) and comprised of areas of pseudostratification
Figure 2. Neonatal mouse uterine mesenchyme induces MIXL1 expression in MIXL1
GFP/w EBs. (A) nMUM induced GFP expression in
MIXL1
GFP/w EB recombinants after three days of co-culture (3
rd panel), representative example of n.100. The duration of reporter activation is
comparable to that observed in growth factor treated EBs (2
nd panel, days 3,5), while little to no reporter activity was detected in the control (1
st
panel) (n.100) (640 magnification, first 3 panels are fluorescent images, images in 4
th panel represent phase contrast images of recombinants in 3
rd
panel). (B) Co-culture of two nMUM pieces (0.5 mm) with a larger EB (.4000 cells) activated reporter activity locally (dotted area is the EB) (620
magnification). (C) No reporter activity was detected in embryoid bodies co-cultured with neonatal uterine epithelium (0.5 mm) (640 magnification).
Areas marked as mesenchyme in recombinants are based on morphological evidence and recombination experiments using ENVY hESC (refer to
Figure S2A–C). Abbreviations: EB, embryoid body; E, neonatal mouse uterine epithelium; GF, growth factors; M, neonatal mouse uterine mesenchyme.
doi:10.1371/journal.pone.0021136.g002
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epithelium [24]. To determine the stage of development, we
examined expression of known MD developmental markers such as
PAX2 and HOXA10 [25]. PAX2 expression first appears after MD
specification, during the elongation stage of development [26].
Although at 2 weeks, PAX2 and HOXA10 expression was not
detected in the hESC derived FRT epithelium (Figure 4B–C), at 4
weeks, HOXA10 and PAX2 expression was observed in the
developing hESC derived FRT epithelium (Figure 4D–E, Figure
S5A, Figure S5B), consistent with the temporal expression pattern
Figure 3. Neonatal mouse uterine mesenchyme induces expression of primary germ layer markers in ENVY/nMUM recombinants.
Real time PCR analysis of RNA collected from EB and recombinants cultured in serum-free BPEL medium. Growth factors (BMP4, 50 ng.ml
21 and
ACTIVIN A, 20 ng.ml
21) were added immediately after forced aggregation of hESCs. Neonatal mouse uterine mesenchyme was added 24 hours after
EB formation into either growth factor treated or untreated EB culture. Expression of genes relative to GAPDH were analysed by quantitative RT-PCR
after 3, 5, 7 and 9 days incubation. Expression of target genes in undifferentiated hESCs is indicated as day 0 of differentiation (Data is plotted as
mean6s.e.m., n=3 independent differentiation experiments). Abbreviations: GF, growth factor; nMUM, neonatal mouse uterine mesenchyme.
doi:10.1371/journal.pone.0021136.g003
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MD development in mice [25,27]. Co-expression of CK18
(Figure 4G) and Vimentin (Figure 4H, Figure S5C) in cells present
on serial sections suggested that the hESC derived FRT epithelium
was meso-epithelial in character. In addition, the expression of
CA125 (Figure 4I, Figure S5D) supports our hypo-
thesis that like human and rodent MD, hESC derived MD
originates from a coelomic-like epithelia [12,28]. The complete
absence of ERa in the hESC derived MD epithelium (Figure 4J)
at this stage of development is consistent with previous reports
showing human fetal MD lacks ERa expression [29]. Motile
b-tubulin-expressing cilia were not detected on the hESC-derived
FRTepithelium(datanot shown).Wethenopticallyreconstructeda
hESC derived FRT gland from stained serial sections (de-
picted from Figure 4E–J), and found it was ductal in character
(Figure 4K). These data indicate that following in vitro dif-
ferentiation, nMUM induced MD differentiation from hESCs
recapitulated some of the known sequential stages MD ontogeny.
Discussion
Very few studies have examined the developing human MD
[24,30,31] and none have examined the differentiation of hESCs
to mesoepithelial derivatives. In this study we established a model
of MD development, providing an opportunity to investigate
factors affecting the genesis of the human FRT. In contrast to
recent work where nMUM was used to differentiate spermatogo-
nial stem cells into murine uterine epithelium [10], developmental
stages observed in our model are similar to normal Mu ¨llerian
organogenesis, making it an ideal platform to study human FRT
development (Figure 5). Our current protocol involves two distinct
stages; hESCs were first differentiated towards cells expressing
mesodermal markers in vitro, and then transplanted in vivo to
form the hESC derived FRT epithelium expressing markers of the
MD and its derivatives. To our knowledge, this is the first report of
hESC differentiation into mesodermally derived epithelium, in this
case the human FRT epithelium.
Figure 4. Morphological and immunohistochemical characteristics of hESC derived FRT epithelial structures in grafted GF treated
recombinants. (A) H&E showing pseudostratification in the hESC derived FRT epithelium surrounded by co-transplanted mouse stroma in a 4 week
graft. (B)n oPAX2 or HOXA10 (C) expression in week 2 hESC derived FRT epithelium (B, C) were serial sections representative of two week 2 graft)
(arrows point to HOXA10
+ mouse stromal cells). (D–I) Representative sections from two different 4 week grafts, (E–J) serial sections of a single gland
(sectioned at 3 mm), (D, E) Nuclear expression of HOXA10 and PAX2 in hESC derived FRT epithelium at 4 weeks. (F) representative serial sections of the
same gland depicted from (E–J) showing GFP
+ hESC derived epithelium surrounded by GFP
2 mouse uterine stromal cells. The gland co-localised
cytoplasmic expression of (G) CK18 and (H) Vimentin in hESC derived FRT epithelium. (I) CA125 expressed on hESC derived FRT epithelium surface. (J)
ERa expressed in transplanted mouse stromal cells but absent from hESC derived FRT epithelium. Insets in (B) is a positive control of PAX2 expression
in adult human endometrial epithelium, inset in (C) concentration matched goat IgG negative control, inset in (E) concentration matched rabbit IgG
negative control, inset in (I) mouse IgG1 negative control for (G–I). (K.1–2) 3D reconstruction of hESC derived FRT epithelium from serial sections
depicted in (E–J) (arrow) shown on the Y-axis, (K.2) shown on the Z-axis view as a duct. Abbreviations: E, epithelium; hFRT, hESC derived FRT;
HOXA10, Homeobox A10; PAX2, Pair box gene 2; S, stroma.
doi:10.1371/journal.pone.0021136.g004
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recombinant grafts, we examined a short list of commonly known
morphological and immunohistochemical markers of adult human
female reproductive (oviduct/uterine) epithelium used in routine
diagnostic laboratories and other tissue recombination studies
[7,10]; cilia (b-tubulin), CK18, ERa, CA125 and GdA. Our results
indicate only the hESC derived FRT epithelium in our
recombinant grafts expressed this suite of epithelial markers.
Several estrogen-induced functional responses of FRT epithelium
were also demonstrated; increased epithelial proliferation, a
defining feature of the uterine epithelium [8,9,10], and secretion
of GdA. GdA is found in both oviduct (uterine tube) and uterine
epithelium of the female reproductive tract and is produced by
epithelium in response to estrogen or progesterone [13,32]. Low
levels of ERa expression in the hESC derived FRT epithelium
suggests that the action of estrogen on the recombinant structure
may be mediated via ERa in the underlying mouse stroma by a
paracrine mechanism, recapitulating a characteristic feature of
stromal-epithelial interactions in mouse and human reproductive
tract tissue [9]. Other evidence of stromal-epithelial interaction is
the smooth muscle differentiation of the mouse stromal cells,
consistent with previous recombination studies using hESCs and
other urogenital tissues [4,5]. One possible explanation for the
weak expression of ERa is that our model developed in the
absence of endogenous ovarian hormones. However, since MD
development is an estrogen-independent process, the absence of
ovarian hormones did not impair formation and differentiation of
the MD, as expected [15,16]. Together these data suggest that
nMUM directed differentiation of hESCs to become human FRT
epithelium. However, as a recombinant model consisting of mouse
and human cells, one would expect some functional differences
between our hESC derived FRT epithelium and that of the
normal human FRT epithelium especially in the area of hormone
responsiveness of the tissue as demonstrated previously in other
uterine recombinant models [9]. In future experiments, for further
characterisation of the hESC derived FRT epithelium, we plan to
compare the molecular signatures between our FRT epithelium
with the normal human FRT epithelium.
Animal studies have shown that coelomic epithelium is specified
to form the MD [28]. During embryogenesis, the coelom itself
Figure 5. Schematic of the proposed Human Mu ¨llerian Duct development model and its potential applications. Stages of
development of the hESCs/nMUM recombinant in vitro and in vivo. Key stages are numbered from 0–5 accompanied by some stage specific markers.
(0): Undifferentiated hESC cells (white circles) were recombined with nMUM (black ovals), (1): primitive streak formation: nMUM (black ovals) induced
some hESC to differentiate into MIXL1
+ mesendodermal cells (green circles) whilst the rest remained either as undifferentiated (white circles) or
belonging to the ectodermal lineage (blue circles), (2): germ layer induction: mesodermal cells (yellow circles) derived from MIXL1
+ mesendodermal
cells in the previous stage, other colored circles represent a variety of differentiated (purple, orange, blue) and undifferentiated cells (white circles),
(3): in vivo differentiation, and formation of a pre-Mu ¨llerian epithelium (yellow) possibly derived from mesodermal cell types in the EB (the presence
of tissues from other lineages is omitted from this figure for illustration purposes), (4): transition from the pre- Mu ¨llerian epithelium into MD
epithelium (red), (5): maturation of MD epithelium into adult FRT epithelium (pink) containing residual MD epithelial cells (in red). Text boxes (below
schematic) include potential applications of the model at different stages of development.
doi:10.1371/journal.pone.0021136.g005
hESC Differentiation by Uterine Stroma
PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e21136derives from the lateral plate mesoderm that emanates from the
primitive streak [33]. Similar to ontological development, our gene
expression analysis indicated that nMUM first initiated mesendo-
derm differentiation and then influenced mesodermal lineage
commitment in the differentiating human EBs. Rather than simply
acting as an external cue to initiate EB self-organisation [34], our
results suggest nMUM created morphogen gradients that in-
fluenced lineage commitment of differentiating hESCs, similar to
other co-culture experiments [35]. Our previous microarrayanalysis
in the nMUM (unpublished data) showed gene expression of several
members of the TGF-beta super family of ligands (BMP, Activin)
and Wnt family ligands consistent with other reports [36,37,38]. We
propose that these and other morphogens in the nMUM initiated
formation of mesendodermal cells and their subsequent differenti-
ation in the EB. Further investigations are required to unravel the
exact combination of mesenchymal soluble factors responsible for
this induction. Following in vitro mesodermal lineage commitment,
subsequent in vivo development of the hESC derived FRT
epithelium at earlier time points mimicked known stages of MD
development [27], both in morphological and molecular features
previously described for human and mouse MD [24,28].
A persistent problem in developing both in vitro and in vivo
human organogenesis models from hESCs is the heterogeneity of
tissue types produced. Similar to recent tissue recombination
studies involving pluripotent cells [4,5,10], our method employing
organ specific mesenchyme for generation of human FRT
epithelium also generated a large fraction of ‘off target’ cell types.
Although, manipulating the ratio of mesenchyme and hESCs
could enhance differentiation and reduce unwanted lineage
differentiation [4], a more consistent and robust outcome might
be achieved if the appropriate inductive growth factors could be
identified. In this study, we combined both techniques by first pre-
differentiating EBs in the presence of mesendoderm promoting
factors and then recombining them with inductive mesenchyme.
Future studies aimed at identifying mesenchymally derived
inductive factors will enable further refinement and control over
the direction and efficiency of differentiation.
Overall, we demonstrated for the first time that nMUM can direct
differentiation of hESCs to form human FRT epithelium. The entire
process can be dissected and studied over a period of 8 weeks
(Figure 5), providing an avenue to investigate human MD develop-
ment. Both host environment and mesenchyme can be manipulated
to examine systemic and local factors involved in MD development
and maturation. Furthermore, our model of human FRT develop-
ment may also provide a platform for the characterisation of human
endometrial stem/progenitor cells recently identified in human and
mouse uterus [1,2,39]. Indirect evidence suggests that stem/pro-
genitor cells reside in the basalis (non-shedding layer) of the
endometrium and it is postulated that they are remnants of fetal
MD epithelium [40]. However, the isolation and identification these
cells have been hampered by lack of defining cell surface markers. In
this context, the availability of hESC derived fetal human MD
epithelium may facilitate the search for cell surface markers that can
be used to locate rare adult stem cells residing in the adult human
uterus. Identifying these cells has the potential to profoundly impact
on understanding normal physiological processes and diseases
affecting the female reproductive tract epithelium, such as endo-
metriosis, endometrial hyperplasia and endometrial cancer [41,42].
Materials and Methods
Animals
Animals were obtained from Monash Animal Services. Day 1
nMUM and epithelium were obtained from female C57BL
/6JAsmu (F1) mice. Female NOD.CB17-prkdcscid/Asmu (NOD.
Scid) and NOD/Scid II-2R Gamma (NSG) mice 4–6 weeks old
were housed under controlled environmental conditions at 20uC
with 12-hour dark/light cycles and unlimited access to food and
water. All animal handling and procedures were carried out in
accordance with National Health and Medical Research Council
of Australia guidelines for the Care and Use of Laboratory Animal
Act and approval was obtained from the Monash University
Animal Ethics Committee at Monash Medical Centre – A (MMC-
A), Clayton, Australia. The approval numbers are 2006/44 and
2010/41.
hESC Lines and Tissue Recombination
Two genetically modified hESC lines were used; the constitu-
tively GFP
+ line, ENVY [18] and MIXL1
GFP/wt reporter line [17],
both of which were derived from HES3 (karyotype 46, XX) [43].
For differentiation experiments, 3000 hESCs per well were
aggregated by centrifugation to form spin EBs in serum-free
BPEL medium according to previously established protocols [44,
45]. In some experiments, the medium was supplemented with
50 ng.ml
21 BMP4 and 20 ng.ml
21 ACTIVIN A (both from R&D
Systems). The uterine tubes of postnatal day 1 mice were me-
chanically dissected following enzymatic treatment as described
in previous studies [7,46]. Two small pieces of epithelial-free
mesenchyme measuring 0.5 mm were recombined with day 1 EBs
by co-culture in serum-free BPEL medium with or without growth
factors (BMP4, 50 ng.ml
21, ACTIVIN A 20 ng.ml
21). On day 3
or 5, recombinants were re-suspended in 10 ml of neutralised rat
tail collagen (a gift from Dr. Renea Taylor, Anatomy and
Developmental Biology, Monash University, Australia) and placed
on the surface of non-adherent Petri dishes for 10–15 minutes at
37uC to allow the gel to solidify. Medium was then added to the
Petri dish and recombinants in collagen droplets were immersed in
the medium and incubated at 37uC for 30 minutes prior to
transplantation into NOD.Scid or NSG mice.
Xenografting tissue recombinants
Tissue recombinants or mesenchyme alone and differentiated
hESCs alone (EBs) were grafted under the renal capsule of female
(5–6 weeks old) NOD.Scid or NSG mice for 2 to 8 weeks as
previously described [5,47]. All mice were ovariectomized at the
time of surgery. For experiments assessing the functional capacity
of hESCs-derived reproductive tract epithelium, animals were
subjected to hormonal treatment one week before harvesting.
Hosts carrying tissue recombinants were injected daily with 500 ng
estradiol valerate (E2) in 100 ml corn oil (experiment group) or
corn oil alone (control group) for 5 days. All grafts were harvested
and fixed overnight in 4% paraformaldehyde (PFA), imaged,
paraffin embedded and 3 mm serial sections cut for histology and
immunohistochemistry. Some recombinants were harvested on
day 5 following in vitro incubation for histology. These grafts were
first re-suspended in collagen and fixed with 4% PFA prior to
processing.
Real time PCR
Individual recombinants and EBs were harvested from in vitro
culture for gene expression analysis on days 3, 5, and 7, and 9.
Samples were incubated in TrypLE Select (Invitrogen) for
30 minutes at 37uC then disaggregated by mixing, and digested
completely with Lysis Solution provided with the RNA extraction
kit (Ambion, Applied Biosystems, CA,). Following RNA extrac-
tion, DNase treatment was performed to eliminate contaminating
genomic DNA using RNaqueous Micro DNase Treatment Kit
(Ambion, Applied Biosystems). The quality and quantity of the
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1000 in conjunction with ND-1000 V3.3.1 computer software
(Thermofisher Scientific). Approximately 50 ng of total RNA from
each sample was reverse transcribed to first strand cDNA with
random hexamer primers using Superscript III reagents with
RNase Inhibitor (Invitrogen). Real-time PCR was performed using
Taqman gene expression probes, Taqman reagents and the 7900
HT Fast Real-Time PCR system absolute thermal cycler with
software from Applied Biosystems. PCR reactions for all samples
were run in triplicates. The comparative cycle threshold (Ct)
method was used to analyse data. Gene expression levels were
compared to the reference gene (REF), glyceraldehye-3-phosphate
dehydrogenase (GAPDH). Since gene expression is inversely
proportional to the Ct, the expression for target gene relative to
GAPDH was calculated according to previously described formula
below [48,49].
Gene expression!
1
2Ct Gene{REF ðÞ
For purposes of presentation, we multiplied calculated values
normalised to GAPDH by 1,000.
We tested for species cross reactivity of individual genes from
information available on manufacturer’s website; we performed a
BLAST search using the amplicon to determine the gene’s location
in the human genome (GenBank mRNA reference numbers)
against the mouse genome. The species specificity of each assay was
tested by including neonatal uterine mesenchyme and human tissue
in real time PCR reactions (data not shown). The inventoried
Taqman Gene Expression Assays (Applied Biosystems) used in this
study were: GAPDH: Hs99999905_m1, MIXL1: Hs00430824_g1,
BRACHYURY: Hs00610080_m1, GOOSECOID: Hs00418279_m1,
OSR1: Hs00377071_m1, PAX2: Hs01057415_m1, POU5F1
(OCT4): Hs03005111_g1. The ID suffix ‘‘_m’’ indicates the probe
spans an exon junction and will not detect genomic DNA. ‘‘_g’’
indicates an assay that may detect genomic DNA. The assay
primers and probes may also be within a single exon. While
genomic DNA amplification was possible for MIXL1 and POU5F1,
this was highly unlikely because of the DNase digestion step after
RNA purification.
Immunohistochemistry/Immunofluorescence
Sections were deparaffinized and hydrated through xylene and
graded alcohols. Antigen retrieval was performed by microwaving
sections in 0.01 M citrate buffer solution, pH-6 for 20 min,
followed by cooling to room temperature. Sections stained with
antibodies specific for nuclear proteins were permeablized with
0.5% Triton-X 100 in PBS for 10 minutes. Endogenous pero-
xidase activity was blocked with 3% H2O2 in methanol for
10 minutes at room temperature followed by 3 rinses with PBS.
Protein Block was applied to minimise non-specific antibody
binding (Serum-free protein block, DAKO, Denmark) for
10 minutes at room temperature. Concentration matched mouse
IgG isotype negative controls were included in each run, rabbit
IgG (DAKO) and goat IgG (Santa Cruz) were included in runs
using polyclonal antibodies as negative controls. Following over-
night incubation with primary antibodies at 4uC in a humidified
chamber, slides were washed with PBS, and incubated with
reagents from appropriate kits or stained with Alexa Fluor
secondary antibodies (Table 1) at 1:200, RT for 30 minutes;
Mouse or Rabbit ENVISION (DAKO), LSAB HRP for Mouse/
Rabbit/Goat (DAKO) were used according to manufacturer’s
protocols. Immunoreactivity was detected by incubating with DAB
(DAKO) for 10–15 minutes, then rinsing with distilled water,
followed by haematoxylin counterstain. Refer to (Table 1) for a list
of primary antibodies used in this study. Hoechst 33258 staining
was performed for 30 seconds (Molecular Probes, Eugene,
Oregon, USA). Bright field images were taken with an Olympus
upright microscope (Olympus Corporation, Tokyo, Japan). Fluo-
rescent images were taken with a Leica DMR upright fluorescence
microscope (Leica Microsystems, Mannheim, Germany). Individ-
ual color images were merged using Image J analysis software.
Adult human endometrial sections were included as positive
controls for every staining run.
3D modelling of harvested tissue recombinant
Consecutive H&E and immunohistochemically stained serial
sections of the tissue were imaged in their entirety using the
Olympus DotSlide system (Olympus BX51, Olympus Corpora-
tion, Tokyo, Japan). The system utilised a 1060.3NA objective to
image multiple connected fields-of-view and digitally joined the
images together to form a single image covering the entire tissue
section. The images of consecutive serial sections were then
stacked into a 3D volume and aligned using AutoAligner v6.0.1
(Bitplane AG). The 3D tissue volume was then visualised and
analysed using Imaris v7.0 (Bitplane AG).
Supporting Information
Figure S1 Xenograft size and hESC-derived FRT epi-
thelium orientation. (A) Size of grafts derived from EBs alone,
growth factor (BMP4 and ACTIVIN A) treated EBs alone,
recombinants and growth factor treated recombinants after 8
weeks in vivo incubation. Inset shows mean volume of three
groups; GF EB, GF Recomb, Recomb, data plotted as mean 6
s.e.m. (n=4 per group, except for n=2 for recombinant group).
(B) H&E of a section from week 8 recombinant graft showing
hESC derived epithelium grown in proximity to other epithelial
and connective tissue structures (arrows indicate transplanted
mouse stromal cells) (C) Composite image of a GF recombinant
Table 1. Primary antibody used in this study.
Primary Antibody Species Clone Dilution Source Reference
a-SMA
4 Mouse 1A4 1:100 Dako [1]
Anti-GFP
1 Mouse N/A 1:500 Millipore [50]
Anti-GFP
2 Rabbit N/A 1:500 Abcam
Anti-b –Tubulin* Mouse TUB2.1 1:1000 Sigma-Aldrich [51]
CA125
1 Mouse OC125 1:200 Invitrogen [12]
CK18
1 Mouse DC10 1:500 Dako [52]
ERa
1 Mouse 6F11 1:50 Nova Castra [53]
Glycodelin A
4 Mouse 001-13 1:100 Abcam [54]
HOXA10
3 Goat N/A 1:1000 Santa Cruz [55]
Ki67
4 Rabbit SP6 1:200 ThermoScientific [56]
PAX2
1 Rabbit N/A 1:100 Invitrogen [57,58]
Vimentin* Mouse V9 1:500 Sigma-Aldrich [1]
1secondary antibody: goat anti-mouse IgG1-AlexaFluor 488 (Invitrogen) or
goat anti-mouse IgG1-AlexaFluor 568.
2secondary antibody: donkey anti-rabbit AF 488 or donkey anti-rabbit AF
568 (Invitrogen).
3secondary antibody: donkey anti-goat AF568 (Invitrogen).
4HRP kits; mouse or rabbit envision (Dako) depending on the host species of
the primary antibody.
*primary antibody is CY3 conjugated.
doi:10.1371/journal.pone.0021136.t001
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structure comprising human epithelial cells with smooth nuclei
surrounded by mouse stromal cells with speckled nuclei (arrows).
All images were captured on64 magnification, inset was captured
on 640. (D) H&E of a section from week 4 recombinant graft
showing two hESC derived epithelium in the same field of view
(arrows indicate transplanted mouse stromal cells). Abbreviations:
C, cartilage; E, epithelium; FC, Fluid-filled cavity; GF, growth
factor; K, kidney; R, hESC derived FRT epithelium; S, stroma.
(TIF)
Figure S2 Histogram summarising the percentage of
grafts that contained hESC derived FRT epithelium,
asterix indicates that week 2 & 4 grafts are included.
(TIF)
Figure S3 (A–B) representativeENVYhESCrecombinant
graft in vitro (C) representative H&E section of ENVY
hESC recombinant graft consisting cells with distinct
morphologies, two populations; ENVY hESC and nMUM.
Abbreviations: EB, embryoid body; M, neonatal mouse uterine
mesenchyme.
(TIF)
Figure S4 (A–B) representative section demonstrating
ERa expression in hESC derived epithelium in grafts with
(A) or without (B) E2 treatment (arrows indicating weakly
stained nuclei), full arrows in (A) indicate mouse uterine
stromal cells (C, D) representative sections showing ERa
expression in normal human adult proliferative uterine
glands and stroma. Abbreviations: E, epithelium; S, stroma.
(TIF)
Figure S5 Immunofluorescent images showing co-local-
isation of GFP
+ hESC derived epithelium from 4 week
grafts with (A) HOXA10 (arrows indicate nuclear stain-
ing), (B) PAX2 (arrows indicating partial/diffuse nuclear
staining), (C) VIMENTIN, and (D) CA125 (arrows on cell
surface).
(TIF)
Figure S6 (A–D) are constituents of the composite
images in Figure 1C–F respectively. DAPI stained images in
(E) and (F) are serial sections corresponding to glandular structures
depicted in Figure 1I and 1K respectively illustrating that hESC
derived epithelium (smooth nuclei) is surrounded by mouse stromal
cells (arrows, speckled nuclei). Abbreviations: CA125, Cancer
Antigen 125; E, epithelium; HOX, Homeobox A10; PAX2, Pair
box gene 2; S, stroma; Vim, VIMENTIN.
(TIF)
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